PsychCME and CME Outfitters Announce CE Audioconference: "Providing Individualized Treatment Strategies for Schizophrenia: Lessons from CATIE" Premieres Monday, March 13
PsychCME and CME Outfitters are pleased to announce an upcoming live and interactive evidence-based psychCME TALK series titled "Providing Individualized Treatment Strategies for Schizophrenia: Lessons from CATIE." Offered as a series of 12 live and interactive audioconferences premiering Monday, March 13, 2006, from 1:15–2:15 p. m. ET, the series will focus on disseminating current and clinically relevant information about the efficacy and side effects of different agents used to treat schizophrenia.
Rockville, MD (PRWEB) February 23, 2006
psychCME and CME Outfitters are pleased to announce an upcoming live and interactive evidence-based psychCME TALK series titled "Providing Individualized Treatment Strategies for Schizophrenia: Lessons from CATIE."
Offered as a series of 12 live and interactive audioconferences premiering Monday, March 13, 2006, from 1:15–2:15 p. m. ET, the series will focus on disseminating current and clinically relevant information about the efficacy and side effects of different agents used to treat schizophrenia. This CE activity will be available as a podcast and archived telephone audioconference shortly after the audioconference premiere, and available as an archived webcast and multimedia CD-ROM in April.
Participation in this activity is free, as is obtaining a CE certificate; however, registration is required. Three forms of registration are accepted:
Online: Visit the activity details page at http://www. cmeoutfitters. com/cmea. asp? ID=195 (http://www. cmeoutfitters. com/cmea. asp? ID=195)
Phone: Call 877.CME. PROS (877.263.7767)
Fax: Visit the activity details page at http://www. cmeoutfitters. com/cmea. asp? ID=195 (http://www. cmeoutfitters. com/cmea. asp? ID=195), print and complete the activity details form, and fax to 240.243.1033
Statement of Need:
The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) trial has provided, for the first time, detailed information comparing the efficacy and side effects of existing treatments for schizophrenia. This NIMH-sponsored study assessed 1,460 people between the ages of 18 and 65 who met DSM-IV criteria for schizophrenia. Participants were recruited from the community at large, assigned to interventions already in relatively widespread use, and followed for 18 months. If at any time during the trial an assigned medication was ineffective or not well tolerated, patients were re-randomized to other treatment pathways. To emulate real-world patterns of schizophrenia, CATIE included people with medical comorbidities, substance use disorders, and those currently treated with other medications. Data collection in the study was completed in December 2004, with the initial analysis published in September 2005. The primary outcome of CATIE is all-cause treatment discontinuation, an important clinical endpoint that reflects both clinician and patient judgements about efficacy and tolerability. Secondary outcome measures of CATIE include symptoms, side effects, neurocognitive functioning, and cost-effectiveness. In this evidence-based psychCME activity, CATIE researchers will expand on the initial outcome data, emphasize the importance of providing individualized treatment strategies for patients with schizophrenia, and offer a contextual framework for making responsible, real-world decisions about treating these challenging patients.
Faculty:
Jeffrey A. Lieberman, MD
Chairman, Department of Psychiatry
College of Physicians and Surgeons, Columbia University
Director, New York State Psychiatric Institute
Director, Lieber Center for Schizophrenia Research
Psychiatrist-in-Chief at New York Presbyterian Hospital & Columbia University Medical Center
New York, NY
Scott Stroup, MD, MPH
Associate Professor of Psychiatry
Adjunct Associate Professor of Social Medicine
University of North Carolina-Chapel Hill
Chapel Hill, NC
Learning Objectives:
At the end of this CE activity, participants should be able to:
Compare and contrast the efficacy of the various agents in the CATIE trial. Apply a contextual framework to the CATIE results as new data become available. Identify the factors involved in providing individualized treatment strategies for patients with schizophrenia.
Target Audience:
Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, certified case managers, pharmacists, and other healthcare professionals with an interest in mental health.
Commercial Support:
CME Outfitters, LLC, gratefully acknowledges an educational grant from Eli Lilly and Company in support of this CE activity.
Credit Information:
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Outfitters, LLC, designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.
CNE Credit (Nurses):
This Educational Activity is presented by CME Outfitters, LLC, which has been approved as a provider of continuing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. It has been assigned code 5UYSJZ-PRV - 0491. 1.2 contact hours (Pharmacology)
CEP Credit (Psychologists):
CME Outfitters, LLC, is approved by the American Psychological Association to sponsor continuing education for psychologists. CME Outfitters, LLC, maintains responsibility for this program and its content. (1.0 CE credits)
NASW Credit (Social Workers):
This program was approved by the National Association of Social Workers (provider #886407722) for 1 continuing education contact hour.
CCMC Credit (Certified Case Managers):
This program has been approved for 1 hour by the Commission for Case Manager Certification (CCMC).
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Program Number: 376-999-06-007-L01 (live interactive session) 376-999-06-007-H01 (recorded activities)
To receive credit, participants must review all activity materials in their entirety, score 70% or above on a post-test, and fully complete and return both the credit request form and activity evaluation. A certificate or statement of credit will be mailed within 4-6 weeks to all who successfully complete these requirements.
About CME Outfitters:
CME Outfitters is a full service healthcare communications agency providing continuing education content development, production, marketing, accreditation, and project management services to the healthcare industry. Among its many collaborative ventures, CME Outfitters has played a primary role in the production, certification, marketing, and logistical support for the popular psychCME series of educational activities. For more information on CME Outfitters, including a complete calendar of its free award-winning educational activities, please visit http://www. cmeoutfitters. com (http://www. cmeoutfitters. com), or call 877.CME. PROS (877.263.7767).
To view all of CME Outfitters' recent press releases, visit http://www. cmeoutfitters. com (http://www. cmeoutfitters. com) and click on "CME Outfitters in the News" or visit http://www. prweb. com (http://www. prweb. com) and search for "CME Outfitters."
PsychCME EXTRA, a weekly e-newsletter published by CME Outfitters, is a convenient way to stay informed of all psychCME news and information. To subscribe, visit http://www. cmeoutfitters. com (http://www. cmeoutfitters. com) and click on "Register for Updates."
Contact: Karen Matthias
CME Outfitters, LLC
240.243.1327 direct
614.430.0288 fax
# # #
